Sample Sidebar Module

This is a sample module published to the sidebar_top position, using the -sidebar module class suffix. There is also a sidebar_bottom position below the menu.
Login
Register

Sample Sidebar Module

This is a sample module published to the sidebar_bottom position, using the -sidebar module class suffix. There is also a sidebar_top position below the search.
Transplantation
Title Phase II study of myeloablative conditioning followed by unmanipulated haploidentical bone marrow transplantation and post-transplant high dose cyclophosphamide for patients with hematologic malignancies
Principal Investigator Riad El Fakih
Mahmoud Aljurf
Address Adult Hematology/ Bone Marrow Transplantation
Oncology Center, MBC-64
King Faisal Specialist Hospital and Research Center
POB 3354
Riyadh 11211, KSA
Contacts Riad El Faikh | Email: [email protected]
Mahmoud Ajurf | Tel: +966 11 464 7272 ext 24586 | Email: [email protected]
Clinicaltrials.gov Identifier Pending
Link Pending

Acute Leukemia - AML
Title Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and G-CSF Combination for Patients with Relapsed or Refractory AML
Principal Investigator Ibraheem Motabi, MD
Address Consultant and Chairman, Adult Hematology and BMT
Comprehensive Cancer Center, King Fahad Medical City
Riyadh 11525, Saudi Arabia
Contacts Ibraheem H Motabi, MD | Tel: +966 11 288 9999 ext 11998 | Email: [email protected]
Humariya H Munshi | Tel: +966 11 288 9999 ext 14029 | Email: [email protected]
Clinicaltrials.gov Identifier NCT02275663
Link

https://clinicaltrials.gov/ct2/show/NCT02275663?term=motabi&rank=1